Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cohort Survey on Shock and Anaphylaxis in Persons With Underlying Diseases Considered to Be at High Risk of Severe COVID-19 by Using Vaccination Information

NCT05894499 is registered in ClinicalTrials.gov with ModernaTX, Inc. as lead sponsor.

NCT NCT05894499
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05894499 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cohort Survey on Shock and Anaphylaxis in Persons With Underlying Diseases Considered to Be at High Risk of Severe COVID-19 by Using Vaccination Information
Lead sponsor
ModernaTX, Inc.
Phase
Observational
Overall status
Completed
Start date
November 15, 2022
Completion date
May 26, 2023
Enrollment
13,309 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov-2